Alnylam Executives Stack Shares Amid Surge in Social‑Media Buzz, Sending a Bullish Signal to Investors
Alnylam insider buying signals confidence: Pushkal’s fresh shares, CEO and CFO activity, and analyst upgrades hint at a high‑growth biotech rally—watch the next clinical milestone to gauge real upside.
10 minutes to read